Evaluation of 2, 3, 5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats

Stroke

Volumn 17, Issue 6, 1986, Pages 1304-1308

  Bederson, Joshua B ^a   Pitts, Lawrence H ^a   Germano, Sabelle M ^a   Nishimura, Merry C ^a   Davis, Richard L ^a   Bartkowski, Henry M ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRIPHENYLTETRAZOLIUM;

ANIMAL EXPERIMENT; BRAIN INFARCTION; CENTRAL NERVOUS SYSTEM; DIAGNOSIS; GREAT BLOOD VESSEL; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PERIPHERAL VASCULAR SYSTEM; PRIORITY JOURNAL; RAT; STAINING;

ANIMALS; BRAIN; CEREBRAL INFARCTION; EOSINE YELLOWISH-(YS); HEMATOXYLIN; MALE; RATS; RATS, INBRED STRAINS; STAINING AND LABELING; TETRAZOLIUM SALTS; TIME FACTORS;

EID: 0022870943     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/01.STR.17.6.1304     Document Type: Article

References (30)

1. Siesjo BK: Cell damage in the brain: a speculative synthesis. J Cereb Blood Row Metabol 1: 155-185, 1981
2. Chasan JL: Nervous System. In: Anderson WAD, Kissane JM (eds): Pathology, 7th ed. St. Louis: CV Mosby, pp 2074-2148, 1977
3. Garcia JH: Ischemic injuries of the brain. Morphologic evolution. Arch Pathol Lab Med 107: 157-161, 1983
4. Garcia JH, Kamijiyo Y: Cerebral infarction: Evolution of histopathological changes after occlusion of a middle cerebral artery in primates. J Neuropathol Exp Neurol 33: 409-421, 1974
5. Stowell RE: Effect on tissue volume of various methods of fixation, dehydration, and embedding. Stain Technology 16: 67, 1941
6. von Pechman H, Runge P: Oxydation der formazyluerbindungen. Ber Deutsch Chem Ges 27: 2920-2930, 1894
7. Glenner GG: Tetrazolium salts. In: Little RD (ed): H. J. Conn’s Biological Stains. Baltimore: Williams & Wilkins, pp 154-162, 1969
8. Sandritter W, Jestadt R: Triphenyltetrazolium chloride (TTC) als reduktionsindikator zur makroskopischen diagnoses des frischen herzinfarktes. Verh Dsch Ges Pathol 41: 165, 1958
9. Orten JM, Neuhaus OW: Human Biochemistry, 9th ed. St. Louis: CV Mosby, pp 173-252, 1975
10. Lie JT, Parolero PC, Holley KE, Titus JL: Macroscopic enzymemapping verification of large, homogeneous experimental myocardial infarctions of predictable size and location in dogs. J Thor Cardiov Surg 69: 599-605, 1975
11. Kloner RA, Darsee JR, DeBoer LWV, Carlson N: Early pathological detection of acute myocardial infarction. Arch Pathol Lab Med 105: 403-406, 1981
12. Fallon JT: Simplified method for histochemical demonstration of experimental myocardial infarct. Circulation 60 (suppl 2): 11-42, 1979
13. Kloner RA, Braunwald E, Maroko PR: Long-term preservation of ischemic myocardium in the dog by hyaluronidase. Circulation 58: 220-226, 1978
14. Ribeiro LGT, Yasuda T, Lowenstein E, et al: Comparative effects on anatomic infarct size of verapamil, ibuprofen, and morphinepromethazine, chlorpromazine combination. Am J Cardiol 43: 396, 1979
15. Rude RE, Kloner RA, Tumas J, et al: Reduction of experimental myocardial infarction size by ortho-iodo sodium benzoate. Am J Cardiol 45: 485, 1979
16. Han D, Zervas NT, Geyer RP, et al: Can perfluorochemicals reduce cerebral ischemia? In: Reivich M, Hurtig HI (eds): Cerebrovascular Diseases. New York: Raven Press, pp 409-419, 1983
17. Bose LB, Jewell LO, Berry R: A reproducible experimental model of focal cerebral ischemia in the cat. Brain Res 311: 385-391, 1984
18. TamuraA, Graham DI, McCullogh J, Teasdale GM: Focal cerebral ischemia in the rat: 1. Description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metabol 1: 53-60, 1981
19. Fishbein M, Meerbaum S, Rit J, et al: Early phase acute myocardial infarct size quantification: validation of the triphenyltetrazolium chloride technique. Am Heart J 101: 593-600, 1981
20. Jennings RB: Early phase of acute myocardial ischemic injury and infarction. Am J Cardiol 24: 753-765, 1969
21. Fine G, Morales A, Scherpella J: Experimental myocardial infarction. Arch Pathol 82: 4-8, 1966
22. Hamolsky MW, Kaplan N: Measurements of enzymes in the diagnosis of acute myocardial infarction. Circulation 23: 102-110, 1961
23. Kalimo H, Rehncrona S, Soderfeldt B: The role of lactic acidosis in the ischemic nerve cell injury. Acta Neuropathol Suppl 7: 20-22, 1981
24. Arsenio-Nunes ML, Hossman KA, Farkas Bargeton E: Ultrastructural and -13-histochemical investigation of the cerebral cortex of the cat during and after ischemia. Acta Neuropathol 26: 329-344, 1973
25. Marshall LF, Graham DI, Durity F, et al: Experimental cerebral oligemia and ischemia produced by intracranial hypertension, Part 2: Brain morphology. J Neurosurg 43: 318-322, 1975
26. Brierley JB, Ljünggrcn B, Siesjö BK: Neuropathological alterations of rat brain after complete ischemia due to raised intracranial pressure. In Lundberg N, Ponten W, Brock M (eds): Intracranial Pressure, vol. 12. Berlin: Springer-Verlag, pp 167-171, 1975
27. Ebhardt G, Mies G, Aier LM, et al: Neuronal injury following permanent middle cerebral artery occlusion in rats. Acta Neuropathol 60: 70-74, 1983
28. Jdrgensen MB, Diemer NH: Selective neuron loss after cerebral ischemia in the rat: possible role of the transmitter glutamate. Acta Neurol Scand 66: 536-546, 1982
29. Nordstrom CH, Rehncrona S: Postischemic cerebral blood flow and oxygen utilization in rats anesthetized with nitrous oxide or phenobarbital. Acta Physiol Scand 101: 230-240, 1977
30. Rehncrona S, Mela L, Siesjö BK: Recovery of brain mitochondrial function after complete and incomplete cerebral ischemia. Stroke 10: 437-446, 1979